27 January 2017

Smith & Nephew retains FTSE4Good status for 16th year

Smith & Nephew, (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce that it has retained its membership of the FTSE4Good index following the most recent review.

The FTSE4Good Series is designed to help investors integrate environmental, social and governance (ESG) factors into their investment decisions. The indexes identify companies that better manage ESG risks and are used as a basis for tracker funds, structured products and as a performance benchmark. The ESG Ratings are used by investors who wish to incorporate ESG factors into their investment decision-making processes, or as a framework for corporate engagement and stewardship.

In the latest review, Smith & Nephew scored well across the three pillars of sustainability, (Environmental, Social and Governance). Having been a member of the FTSE4Good index since 2001 this announcement is further reinforcement of our continued excellence in sustainable operations. It follows last year's announcement of retaining our position as an index component on the Dow Jones Sustainability Indices (DJSI) for the fourteenth consecutive year.

Olivier Bohuon, Chief Executive Officer of Smith & Nephew, said:

"We are firmly committed to making a meaningful contribution across all three pillars of sustainability. Our emphasis is on delivering positive outcomes that advance the long-term prospects for our business everywhere we operate. We will continue to strive to be a responsible business that sets an example for others."